Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of AQ-Art vs CDA for Uncomplicated Malaria in Malawi
NCT00164359Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Apr 2005
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amodiaquine in Plasmodium falciparum malaria, sponsored by Centers for Disease Control and Prevention. Started Apr 2005; status: completed.
02
Drugs
amodiaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00164359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00164359.